Distribution and Antibiotic Resistance Pattern of Bacteria Isolated from Patients with Community-acquired Urinary Tract Infections in Iran: A Cross-sectional Study

سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 34

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJHS-4-2_004

تاریخ نمایه سازی: 29 بهمن 1402

چکیده مقاله:

Background: Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Multi-drug resistance (MDR) and extensively-drug resistance (XDR) in bacteria is an alarming problem in the world. The aim of this study was to detection of etiologic agents associated with community-acquired urinary tract infections (CA-UTIs) and investigation of antibiotic susceptibility patterns.Methods: This study was performed from September ۲۰۱۴ to March ۲۰۱۵ on outpatients, which referred to Labbafinejad Hospital Clinic, Tehran, Iran. The bacterial pathogenic diversity identified by standard laboratory methods. The antimicrobial resistance rates were performed by Kirby Bauer disc diffusion methods.Results: A total of ۳۰۳ patients were enrolled in this study, from which ۲۰۴ (۶۷.۳%) were female and ۹۹ (۳۲.۵%) were male patients. Escherichia coli was the dominant species (۶۹%), followed by Enterococcus faecalis (۱۲.۸%) and Klebsiella pneumoniae (۴.۶%). High resistance rate to nalidixic acid (۷۳.۸%), trimethoprim/Sulfamethoxazole (۵۴.۳%), ciprofloxacin (۵۴.۳%) in E. coli, and tetracycline (۸۹.۷%) in E. faecalis strains and high susceptibility rate to meropenem (۹۶.۶%), imipenem (۹۵.۲%), amikacin (۹۰.۴%), cefoxtin (۸۷.۶%), and nitrofurantoin (۸۲.۸%) in E. coli, and nitrofurantoin (۱۰۰%) in E. faecalis strains were observed. In addition, ۴۳.۵% of the strains were multidrug-resistant (MDR).Conclusions: This study showed that E. coli was the predominant uropathogen of CA-UTIs in this geographical area. It also demonstrated the empirical treatment of urinary tract infections may be difficult due to high resistance to commonly used antibiotics. Continuous monitoring of MDR organisms and drug resistance patterns are needed to prevent treatment failure and reduce selective pressure. These findings suggest the use of nitrofurantoin, cefoxitin, and amikacin in this area of the country.Background: Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Multi-drug resistance (MDR) and extensively-drug resistance (XDR) in bacteria is an alarming problem in the world. The aim of this study was to detection of etiologic agents associated with community-acquired urinary tract infections (CA-UTIs) and investigation of antibiotic susceptibility patterns. Methods: This study was performed from September ۲۰۱۴ to March ۲۰۱۵ on outpatients, which referred to Labbafinejad Hospital Clinic, Tehran, Iran. The bacterial pathogenic diversity identified by standard laboratory methods. The antimicrobial resistance rates were performed by Kirby Bauer disc diffusion methods. Results: A total of ۳۰۳ patients were enrolled in this study, from which ۲۰۴ (۶۷.۳%) were female and ۹۹ (۳۲.۵%) were male patients. Escherichia coli was the dominant species (۶۹%), followed by Enterococcus faecalis (۱۲.۸%) and Klebsiella pneumoniae (۴.۶%). High resistance rate to nalidixic acid (۷۳.۸%), trimethoprim/Sulfamethoxazole (۵۴.۳%), ciprofloxacin (۵۴.۳%) in E. coli, and tetracycline (۸۹.۷%) in E. faecalis strains and high susceptibility rate to meropenem (۹۶.۶%), imipenem (۹۵.۲%), amikacin (۹۰.۴%), cefoxtin (۸۷.۶%), and nitrofurantoin (۸۲.۸%) in E. coli, and nitrofurantoin (۱۰۰%) in E. faecalis strains were observed. In addition, ۴۳.۵% of the strains were multidrug-resistant (MDR). Conclusions: This study showed that E. coli was the predominant uropathogen of CA-UTIs in this geographical area. It also demonstrated the empirical treatment of urinary tract infections may be difficult due to high resistance to commonly used antibiotics. Continuous monitoring of MDR organisms and drug resistance patterns are needed to prevent treatment failure and reduce selective pressure. These findings suggest the use of nitrofurantoin, cefoxitin, and amikacin in this area of the country.

نویسندگان

Fatemeh Fallah ۱

۱. Dept. of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Soha Parhiz ۱

۱. Dept. of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Leila Azimi ۲

۲. Pediatric Infection Research Center, Research Institute for Children Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

marjan rashidan ۳

۳. School of medicine, Shahroud University of Medical Sciences, Shahroud, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: what's ...
  • Najar MS, Saldanha CL, Banday KA. Approach to urinary tract ...
  • Mishra MP, Sarangi R, Padhy RN. Prevalence of multidrug resistant ...
  • Haque R, Akter ML, Salam MA. Prevalence and susceptibility of ...
  • Abejew AA, Denboba AA, Mekonnen AG. Prevalence and antibiotic resistance ...
  • Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract ...
  • Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. ...
  • Komolafe OO. Antibiotic resistance in bacteria - an emerging public ...
  • Jahn LJ, Munck C, Ellabaan MMH, Sommer MOA. Adaptive Laboratory ...
  • Akoachere JF, Yvonne S, Akum NH, Seraphine EN. Etiologic profile ...
  • Mihankhah A, Khoshbakht R, Raeisi M, Raeisi V. Prevalence and ...
  • Frieri M, Kumar K, Boutin A. Antibiotic resistance. Journal of ...
  • D H Bergey JGH. Bergey's manual of determinative bacteriology. 9th ...
  • (CLSI). CaLSI. Performances Standards for Antimicrobial SusceptibilityTesting; Twenty-Fourth Informational Supplement. ...
  • Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, ...
  • O'Brien TF, Stelling J. Integrated Multilevel Surveillance of the World's ...
  • Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, ...
  • van Duin D, Paterson D. Multidrug Resistant Bacteria in the ...
  • Orrett FA. Urinary tract infections in general practice in a ...
  • Gupta S, Kapur S, Padmavathi D. Comparative Prevalence of Antimicrobial ...
  • Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, ...
  • Nozarian Z, Abdollahi A. Microbial Etiology and Antimicrobial Susceptibility of ...
  • Schito GC, Naber KG, Botto H, Palou J, Mazzei T, ...
  • Klingeberg A, Noll I, Willrich N, Feig M, Emrich D, ...
  • Cordoba G, Holm A, Hansen F, Hammerum AM, Bjerrum L. ...
  • Seifu WD, Gebissa AD. Prevalence and antibiotic susceptibility of Uropathogens ...
  • Ehinmidu JO. Antibiotics susceptibility patterns of urine bacterial isolates in ...
  • Lee SJ, Lee DS, Choe HS, Shim BS, Kim CS, ...
  • Nzalie RN, Gonsu HK, Koulla-Shiro S. Bacterial Etiology and Antibiotic ...
  • Sharma I, Paul D. Prevalence of community acquired urinary tract ...
  • Mirzarazi M, Rezatofighi, S.E., Pourmahdi, M., Mohajeri, M.R. Antibiotic Resistance ...
  • Ghanbari F, Khademi, F., Saberianpour, Sh., Shahin, M., Ghanbari, N., ...
  • Ramirez-Castillo FY, Moreno-Flores AC, Avelar-Gonzalez FJ, Marquez-Diaz F, Harel J, ...
  • Thapa P, Parajuli, K., Poudel, A., Thapa, A., Manandhar, B., ...
  • Moroh J-LA, Fleury, Y., Tiac, H., Bahia, C., Lietard , ...
  • Ali I, Kumar N, Ahmed S, Dasti JI. Antibiotic Resistance ...
  • Shilpi T, Ahmed, M.N., Ariful Huq, S.M., Baul, S.K., Khatun, ...
  • Kidwai SS, Nageen A, Ghaznavi S, Bashir F, Ara J. ...
  • Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance ...
  • Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance ...
  • Rashidan M, Ghalavand, G., Eslami, G., Gachkar, L., Rahbar, M., ...
  • Khalid HM. Molecular detection of virulence factors of enterococcus faecalis ...
  • Singhal A, Sharma R, Jain M, Vyas L. Hospital and ...
  • Asadpour L. Antibacterial drug resistance patterns in poultry isolated enterococci. ...
  • نمایش کامل مراجع